Simcere Pharmaceutical Group (NYSE:SCR)

CAPS Rating: 4 out of 5

The Company is a manufacturer and supplier of branded generic pharmaceuticals in the fast growing China market.

Recs

0
Player Avatar Calinvestments (99.16) Submitted: 5/13/2011 1:32:36 PM : Outperform Start Price: $12.39 SCR Score: -29.80

This is a small/mid cap high growth stock that should outperform the S&P during the bull market.

Featured Broker Partners


Advertisement